Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor-Reference-Cited by-同舟云学术

Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor

Published:2021-10-24 Issue:2 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Woods Andrew D.¹^ORCID,Berlow Noah E.¹,Ortiz Michael V.²^ORCID,Dela Cruz Filemon²,Siddiquee Armaan²,Coutinho Diego F.²,Purohit Reshma¹,Freier Katherine E. Tranbarger¹,Michalek Joel E.³,Lathara Melvin⁴,Matlock Kevin⁴,Srivivasa Ganapati⁴,Royer‐Pokora Brigitte⁵^ORCID,Veselska Renata⁶^ORCID,Kung Andrew L.²,Keller Charles¹^ORCID

Affiliation:

1. Children's Cancer Therapy Development Institute Beaverton Oregon USA

2. Department of Pediatrics Memorial Sloan Kettering Cancer Center New York New York USA

3. Department of Population Health Sciences, Joe R. & Teresa Lozano Long School of Medicine University of Texas Health Science Center San Antonio Texas USA

4. Omics Data Automation Inc. Beaverton Oregon USA

5. Institute of Human Genetics, Medical Faculty Heinrich Heine University Duesseldorf Duesseldorf Germany

6. Department of Experimental Biology, Faculty of Science Masaryk University Brno Czech Republic

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29401

Reference52 articles.

1. HowladerNNA KrapchoM GarshellJ et al.SEER cancer statistics review 1975–2015.National Cancer Institute. November 2014 SEER data submission (posted to the SEER website April 2015). Accessed December 15 2018.https://seer.cancer.gov/csr/1975_2015/

2. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study

3. Epidemiology of Wilms tumor

4. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

5. Anaplasia in unilateral Wilms' tumor: A report from the National Wilms' Tumor Study Pathology Center

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors;Nature Communications;2023-11-30

2. BET Bromodomain Inhibitors as an Emerging Class of Anticancer Agents;Handbook of Cancer and Immunology;2023-11-08

3. Targeting the epigenetic reader “BET” as a therapeutic strategy for cancer;Bioorganic Chemistry;2023-11

4. Advances in the clinical management of high‐risk Wilms tumors;Pediatric Blood & Cancer;2023-04-25

5. Advances in the clinical management of high‐risk Wilms tumors;Pediatric Blood & Cancer;2023-01-10